Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Evaluation
 

Efavirenz Dose Reduction in HIV-1 Infected Patient Based on CYP2B6 Genotype
Processing...

MyLikes

MyPaths

Info
Algorithm Information

Efavirenz Dose Reduction in HIV-1 Infected Patient Based on CYP2B6 Genotype

MyLikes

MyPaths
Purpose:
To evaluate an HIV-infected patient for CYP2B6 genotype and its effect on efavirenz dose adjustment.
Specialty
  • Toxicology
    Emergency Medicine
    Critical Care
    Genetics
Objective
  • Dosage adjustments
  • Adverse effects
ICD-10
  • T37.5
References
Interpretation and Description
Share this Algorithm
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Efavirenz Dose Reduction in HIV-1 Infected Patient Based on CYP2B6 Genotype
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.